Marek's Disease Vaccine Market, Global Outlook and Forecast 2023-2030
Marek's Disease Vaccine is used to prevent Marek's disease in chickens, which is the three major diseases that endanger the healthy development of the chicken industry.
This report aims to provide a comprehensive presentation of the global market for Marek's Disease Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Marek's Disease Vaccine. This report contains market size and forecasts of Marek's Disease Vaccine in global, including the following market information:
Global Marek's Disease Vaccine Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global Marek's Disease Vaccine Market Sales, 2018-2023, 2024-2030, (K Units)
Global top five Marek's Disease Vaccine companies in 2022 (%)
The global Marek's Disease Vaccine market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Bivalent Vaccine Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Marek's Disease Vaccine include Merck, Ceva, Zoetis, Boehringer Ingelheim, Guangdong Wen's Dahuanong Biotechnology Co., Ltd., Merial, Ruipu Biopharmaceutical Co., Ltd., Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. and Beijing Huadu Shihua Biological Products Co., Ltd., etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Marek's Disease Vaccine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Marek's Disease Vaccine Market, by Type, 2018-2023, 2024-2030 ($ Millions) & (K Units)
Global Marek's Disease Vaccine Market Segment Percentages, by Type, 2022 (%)
Bivalent Vaccine
Monovalent Vaccine
Global Marek's Disease Vaccine Market, by Application, 2018-2023, 2024-2030 ($ Millions) & (K Units)
Global Marek's Disease Vaccine Market Segment Percentages, by Application, 2022 (%)
Veterinary Pharmacy
Online Sale
Others
Global Marek's Disease Vaccine Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions) & (K Units)
Global Marek's Disease Vaccine Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Marek's Disease Vaccine revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Marek's Disease Vaccine revenues share in global market, 2022 (%)
Key companies Marek's Disease Vaccine sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Marek's Disease Vaccine sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Merck
Ceva
Zoetis
Boehringer Ingelheim
Guangdong Wen's Dahuanong Biotechnology Co., Ltd.
Merial
Ruipu Biopharmaceutical Co., Ltd.
Harbin Pharmaceutical Group Biological Vaccine Co., Ltd.
Beijing Huadu Shihua Biological Products Co., Ltd.
Guangxi Lichengdong Biological Co., Ltd.
Outline of Major Chapters:
Chapter 1: Introduces the definition of Marek's Disease Vaccine, market overview.
Chapter 2: Global Marek's Disease Vaccine market size in revenue and volume.
Chapter 3: Detailed analysis of Marek's Disease Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Marek's Disease Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Marek's Disease Vaccine capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
